Dr. David Wong

Dr. David Wong graduated with Honours from the University of Toronto’s Medical Doctorate program and specializes in vitreous and retina surgery. He completed his ophthalmology residency at the University of Toronto, followed by fellowships with Dr. Michael Shea in Toronto and Dr. Stanley Chang in New York.

Dr. Wong is a Fellow of the Royal College of Physicians and Surgeons of Canada and is certified by the American Board of Ophthalmology. He is also a member of numerous professional organizations, including the Canadian Ophthalmological Society, Canadian Retina Society, American Academy of Ophthalmology, American Society of Retina Specialists, The Retina Society, and the Association for Research in Vision and Ophthalmology.

He is an Associate Professor in the Department of Ophthalmology and Vision Sciences at the University of Toronto and in the Biomedical Engineering Department at McMaster University. He practices at St. Michael’s Hospital, Oakville Trafalgar Hospital, and Trillium Hospital, and serves as Ophthalmologist-in-Chief at St. Michael’s Hospital.

Dr. Wong serves on various hospital and university committees, sits on the board of directors for the 20/20 Ophthalmic Biomaterials Network, advises several industry companies, and is on the steering committee for the Vision Academy and the DR and AMD Barometer projects.

He has received numerous national and international awards, including the American Society of Vitreoretinal Surgeons (ASRS) Senior Award and induction into the Retinal Hall of Fame. He is also one of the pioneers of the Area of Focused Competence (AFC) retina program through the Royal College of Physicians and Surgeons of Canada.

A frequent invited speaker across North and South America, Asia, and Europe, Dr. Wong has authored numerous scientific papers and book chapters on vitreoretinal diseases, including trauma, complex surgery, AMD, retinal vein occlusions, and diabetes. His recent interests include vitreous and vascular imaging, new surgical techniques, and the development of ophthalmic biomaterials.